Am J Transplant, Volume 20, Suppl 3 Archives - Page 100 of 223 - ATC Abstracts

2020 American Transplant Congress
Early Steroid Withdrawal in HIV+ Kidney Transplant Recipients is Associated with Increased Acute Rejection by 1 Year
W. A. Werbel¹, S. Bae², S. Yu³, F. Al-Ammary⁴, C. M. Durand¹, D. L. Segev³
¹Infectious Diseases, Johns Hopkins University, Baltimore, MD, ²Epidemiology, Johns Hopkins University, Baltimore, MD, ³Surgery, Johns Hopkins University, Baltimore, MD, ⁴Nephrology, Johns Hopkins University, Baltimore, MD
*Purpose: Kidney transplantation among HIV+ recipients (HIV+ KT) is increasing, with excellent outcomes. Acute rejection (AR), however, is 2-3-fold more common than in HIV- KT.…
2020 American Transplant Congress
The Impact Of Weight Reduction Surgery And Morbid Obesity On Renal Function After Transplantation
S. Negi¹, N. Saberi¹, P. Bouchard², a. Andalib², M. Cantarovich¹, S. Paraskevas¹, J. Tchervenkov¹
¹RIMUHC, Montreal, QC, Canada, ²McGill University, Montreal, QC, Canada
*Purpose: Morbid obesity is a significant barrier and renal transplantation is rarely offered to patients with Class III obesity (body mass index (BMI) > 40…
2020 American Transplant Congress
Altruistic Liver Donors at Thomas E Starzl Transplant Institute: Impact of the Educational Campaign: Gift of Life
S. Ganesh, M. Molinari, L. Tubb, A. Tevar, C. Hughes, J. Behari, A. Humar
Transplant Surgery, UPMC Thomas E Starzl Transplant Institute, Pittsburgh, PA
*Purpose: Background and aims: There is an urgent need to expand access to living donor liver transplants due to a wide gap in the availability…
2020 American Transplant Congress
Evaluation of the Safety and Efficacy of Valganciclovir to Prevent Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients Utilizing Two Dosing Regimens
K. Le, A. Patel, N. M. Jasiak-Panek
Pharmacy, Ann and Robert H. Lurie Children's Hospital, Chicago, IL
*Purpose: Valganciclovir (VGCV) is FDA-approved for CMV prophylaxis in children aged one month to sixteen years old using the Pescovitz algorithm (7 x body surface…
2020 American Transplant Congress
Risk Aversion in Lung Transplantation: Organ Procurement Organizations Differ in Willingness to Pursue Non-Ideal Donor Organs
S. E. Halpern¹, A. McConnell², S. Peskoe², V. Raman³, O. K. Jawitz³, A. Y. Choi¹, J. C. Haney³, J. A. Klapper³, M. G. Hartwig³
¹Duke University School of Medicine, Durham, NC, ²Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, ³Department of Surgery, Duke University Medical Center, Durham, NC
*Purpose: Lungs from non-ideal deceased donors are disproportionally discarded despite evidence that waitlisted candidates benefit from use of these organs. Organ procurement organizations (OPOs) individually…
2020 American Transplant Congress
Humanized Mouse Reveals the Cytoprotective Function of Hepatocyte RXFP1 in Liver Transplant Recipients
H. Kojima¹, S. Kageyama¹, K. Kadono¹, H. Hirao¹, K. J. Dery¹, T. Ito¹, G. Sugahara², Y. Ishida², T. Saito², F. M. Kaldas¹, R. W. Busuttil¹, J. W. Kupiec-Weglinski¹
¹Surgery, The Dumont-UCLA Transplantation Center, Los Angeles, CA, ²Division of Gastrointestinal and Liver Disease, Keck School of Medicine, USC, Los Angeles, CA
*Purpose: RXFP1 (RLX family peptide receptor 1) is a cognate receptor for relaxin (RLX), an insulin-like growth factor, with vasoactive/remodeling properties. We have documented cytoprotective…
2020 American Transplant Congress
Generation and Long-Term Culturing of AIPCs for Islet Replacement
J. B. Pollett¹, R. Bottino², S. Bertera², M. Trucco², N. Thai²
¹Imagine Pharma, Pittsburgh, PA, ²Allegheny Health Network, Pittsburgh, PA
*Purpose: Islet transplantation is one of the most promising hopes for a cure for type 1 diabetes, although islet shortage remains a serious concern. A…
2020 American Transplant Congress
Financial Analysis of Donor HCV+ Kidney in HCV- Recipients
D. Axelrod¹, K. Lentine², R. Balakrishnan¹, T. Alhamad³, S. Chang³, H. Xiao², B. Kasiske⁴, M. Schnitzler², R. Bloom⁵
¹University of Iowa, Iowa City, IA, ²Saint Louis Univ, Saint Louis, MO, ³Washington Univ, Seattle, WA, ⁴SRTR, Minneapolis, MN, ⁵Univ of Pennsylvania, Philadelphia, PA
*Purpose: Use of organs from viremic hepatitis C positive donors (dHCV+) in recipients without HCV has been demonstrated to improve access to kidney transplant (KTx).…
2020 American Transplant Congress
Early Inflammatory Lesions on Surveillance Biopsies Post Kidney Transplant is Associated with Increased Incidence of Late Clinical Rejections
I. Melgarejo¹, D. Jorgensen², K. Kalra¹, S. Tandukar², C. Puttarajappa², N. Shah², A. Sharma², P. Sood², C. Wu², S. Hariharan², R. Mehta²
¹Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, PA, ²Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA
*Purpose: It is unclear whether subclinical inflammation (or subclinical rejection) noted on early post transplant biopsies are associated with late clinical rejections (beyond 6 months).*Methods:…
2020 American Transplant Congress
Cross-Validation of Performance-Based Frailty against Daily Step Count from Personal Activity Trackers – Refining Prehabilitation Tools in Liver Transplant Candidates
M. A. Hassan¹, M. A. Dunn¹, P. M. Bloomer¹, A. H. Gougol¹, M. Serper², D. R. Jorgensen¹, A. Duarte-Rojo¹
¹Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, ²Department of Medicine, University of Pennsylvania, Philadelphia, PA
*Purpose: The AST proposed a toolkit to identify frailty in liver transplant (LT) candidates, including the liver frailty index (LFI) and 6-min walk test (6MWT).…